Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
Clinical trial NCT06574126 · RECRUITING
Trial details
- NCT number
- NCT06574126
- Sponsor
- PETHEMA Foundation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2032-09-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.